Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-184
Closed -$20.1K 334
2023
Q4
$20.1K Buy
+184
New +$19.1K 0.01% 288
2023
Q3
Sell
-184
Closed -$21.2K 323
2023
Q2
$21.2K Buy
+184
New +$20.9K 0.01% 274
2022
Q4
Sell
-167
Closed -$14K 281
2022
Q3
$14K Buy
167
+1
+0.6% +$89 0.01% 262
2022
Q2
$15K Sell
166
-40
-19% -$3.55K 0.01% 248
2022
Q1
$17K Sell
206
-47
-19% -$3.71K 0.01% 271
2021
Q4
$19K Buy
253
+134
+113% +$10.7K 0.01% 247
2021
Q3
$9K Buy
+119
New +$9.05K ﹤0.01% 306

Other funds holding MRK

O'Dell Group's MRK Position: Q1 2024 in Review

O'Dell Group sold out of Merck (MRK) in Q1 2024, closing a stake of 184 shares — an estimated $20.1K sold.

O'Dell Group first reported a position in MRK in Q3 2021 and held it in 7 quarters. The position peaked at $21.2K in Q2 2023. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • O'Dell Group reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • O'Dell Group sold 184 Merck shares in Q1 2024, an estimated $20.1K.
  • O'Dell Group first reported a position in Merck in Q3 2021 and held it in 7 quarters.
  • O'Dell Group's Merck position peaked at $21.2K in Q2 2023.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on O'Dell Group's 13F filing for Q1 2024, filed 7 May 2024.